Marker Therapeutics Inc
MRKR
$1.12+1.82%
Delayed · as of Sep 30, 2026, 10:47 AM ET
Mkt cap
$25.34M
EV/Sales
2.62
P/E ratio
N/A
FY2025 Revenue
$3.55M
EPS (TTM)
$-0.38
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-342.96%
Beta
1.43
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Marker Therapeutics Inc (MRKR) is a biotechnology company listed on US.
Latest reported MRKR revenue for 2025-12-31 was $3.5M. Net income was -$12.2M. Revenue was down 46.2% from 2024-12-31 to 2025-12-31. MRKR currently screens at market cap $25.3M.
Use this MRKR research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full MRKR income, balance, and cash tables.
Marker Therapeutics Inc (MRKR) is a biotechnology company in the Healthcare sector.
Latest cached Marker Therapeutics Inc (MRKR) revenue for Dec 31, 2025 was $3.5M. Net income was -$12.2M. Statements: https://lician.com/financials/mrkr
Marker Therapeutics Inc (MRKR) market capitalization is $25.3M on the latest cached snapshot.
Marker Therapeutics Inc (MRKR) cached previous close $1.10; day range $1.12 – $1.14; volume 1,582. Session quote: https://lician.com/quote/mrkr
Marker Therapeutics Inc (MRKR) latest cached earnings event is "MRKR earnings" on Aug 14, 2026. Earnings calendar: https://lician.com/earnings